Home
>
National Drug Code (NDC)
>
Zevalin
Zevalin - 68152-103-03 - (ibritumomab tiuxetan)
Drug Information of Zevalin
| Product NDC: | 68152-103 |
| Proprietary Name: | Zevalin |
| Non Proprietary Name: | ibritumomab tiuxetan |
| Active Ingredient(s): | & nbsp; ibritumomab tiuxetan |
| Administration Route(s): | |
| Dosage Form(s): | KIT |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Zevalin
| Product NDC: | 68152-103 |
| Labeler Name: | Spectrum Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | BLA125019 |
| Marketing Category: | BLA |
| Start Marketing Date: | 20020219 |
Package Information of Zevalin
| Package NDC: | 68152-103-03 |
| Package Description: | 1 KIT in 1 CARTON (68152-103-03) * 2 mL in 1 VIAL * 10 mL in 1 VIAL * 2 mL in 1 VIAL |
NDC Information of Zevalin
| NDC Code | 68152-103-03 |
| Proprietary Name | Zevalin |
| Package Description | 1 KIT in 1 CARTON (68152-103-03) * 2 mL in 1 VIAL * 10 mL in 1 VIAL * 2 mL in 1 VIAL |
| Product NDC | 68152-103 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | ibritumomab tiuxetan |
| Dosage Form Name | KIT |
| Route Name | |
| Start Marketing Date | 20020219 |
| Marketing Category Name | BLA |
| Labeler Name | Spectrum Pharmaceuticals, Inc. |
| Substance Name | |
| Strength Number | |
| Strength Unit | |
| Pharmaceutical Classes |
